Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cronos Group Inc (CRON) vs Kyndryl Holdings Inc (KD) Price & Performance

Cronos Group IncTrade
Kyndryl Holdings IncTrade

Price performance (Past 24H)

Key statistics

Cronos Group Inc vs Kyndryl Holdings Inc — how do they compare? Cronos Group Inc trades at $3.22 (market cap $1.18B), while Kyndryl Holdings Inc trades at $11.95 (market cap $2.59B). The key difference: Kyndryl Holdings Inc is far larger — about 2.2× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Kyndryl Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Kyndryl Holdings Inc for 36 Days on average.

CRONKD
Market Cap
$1.18B$2.59B
Volume
968,0375,354,348
Sector
HealthTechnology
52-Week High
$3.55$29.76
52-Week Low
$2.30$10.59
Typical Hold Time
22 Days36 Days
Enterprise Value
$387.62M$5.41B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cronos Group Inc

CRON trades at $3.24, down 1.37% today amid a bearish technical signal. Recent quarterly earnings show beats in Q1 and Q2 2026, with revenue growth from $118M in 2024 to $147M in 2025. The company reported a net loss of $9.45M in 2025 but projects a profit of $70M for 2026. Analyst sentiment is mixed with a 20% buy rating. News highlights focus on international expansion and a recent Investor Day outlining growth strategies.

Outlook is cautiously optimistic given projected profitability in 2026 and strong cash reserves, but risks include sustained negative cash flow and competitive pressures. The stock's valuation metrics like P/E of 16.95 and P/S of 6.84 suggest moderate pricing relative to peers, though high EV/EBITDA of 43 indicates premium expectations.

Kyndryl Holdings Inc

Kyndryl (KD) trades at $11.45, down 0.26% on the day, reflecting a challenging technical and fundamental environment. The stock exhibits a bearish technical signal with key support at $11 and resistance at $12, while recent earnings misses in Q4 2025 and Q1 2026 contrast with a beat in Q2 2026. Despite a low P/S ratio of 0.18 and positive net income of $252 million in 2025, the company's revenue has declined from $18.3B in 2022 to $15.1B in 2025. Recent news highlights a strategic focus on AI, including the launch of an innovation lab and the acquisition of Healthcare IT Leaders.

The outlook for KD is mixed, with a consensus price target of $14.67 suggesting potential upside, but analyst sentiment is cautious with 71% hold ratings. Key opportunities include AI-driven growth and improving profitability, while risks involve persistent revenue declines, high debt levels, and competitive pressures in the IT services sector. Execution on AI initiatives and future earnings performance will be critical for stock appreciation.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CRON

No sentiment data available yet.

KD
100% Buy0% Sell
Avg holding period · 36 Days

Top news

Latest headlines on both assets

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON →

About Kyndryl Holdings Inc

Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.

Read more on KD →